论文信息 - Laboratory detection of extended-spectrum beta-lactamase by an automated system.

Laboratory detection of extended-spectrum beta-lactamase by an automated system.

This study aims to evaluate the positive predictive value (PPV) and the negative predictive value (NPV) of Vitek2 in detecting extended-spectrum beta-lactamase (ESBL) phenotypes when compared to a manual confirmatory test as gold standard. A sample of Escherichia coli, Klebsiella spp and Proteus mirabilis isolates were collected by 5 laboratories in the Emilia-Romagna Region (Italy). Vitek2 appears to be an accurate tool to detect ESBL phenotypes of E. coli isolates; some concern remains about its performance with the other bacterial species, especially P. mirabilis.

[1] M. Pfaller,et al. Overview of the Epidemiological Profileand Laboratory Detection of Extended-Spectrum β-Lactamases , 2006 .

[2] H Mittermayer,et al. Multicentre evaluation of the VITEK 2 Advanced Expert System for interpretive reading of antimicrobial resistance tests. , 2002, The Journal of antimicrobial chemotherapy.

[3] D. Livermore,et al. Efficacy of practised screening methods for detection of cephalosporin-resistant Enterobacteriaceae. , 2006, The Journal of antimicrobial chemotherapy.

[4] Robert A. Bonomo,et al. Extended-Spectrum (cid:2) -Lactamases: a Clinical Update , 2005 .

[5] M. Kaufmann,et al. Molecular epidemiology of multiresistant Escherichia coli isolates from community-onset urinary tract infections in Cornwall, England. , 2006, The Journal of antimicrobial chemotherapy.

[6] D. Livermore,et al. Minimising antibiotic resistance. , 2005, The Lancet. Infectious diseases.

[7] K. Laupland,et al. Emergence of Enterobacteriaceae producing extended-spectrum beta-lactamases (ESBLs) in the community. , 2005, The Journal of antimicrobial chemotherapy.

[8] Kenneth S. Thomson,et al. Ability of the VITEK 2 Advanced Expert System To Identify β-Lactam Phenotypes in Isolates of Enterobacteriaceae andPseudomonas aeruginosa , 2000, Journal of Clinical Microbiology.

[9] M. Pfaller,et al. Overview of the epidemiological profile and laboratory detection of extended-spectrum beta-lactamases. , 2006, Clinical Infectious Diseases.